GCNT2 and metastatic malignant neoplasm in the lymph nodes: Nakamura et al. reported that GCNT2 expression is regulated by DNA methylation, and hypomethylation of the GCNT2 promoter which is closely associated with lymph node metastasis and poor prognosis [21].